COVID-19 treatment: NIH study aims to determine safety and efficacy of experimental monoclonal antibodies
by Press Release from Outbreak News Today on (#56HGQ)
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized, controlled trial is known as ACTIV-3, and as a master protocol," it is designed to expand to test multiple different kinds [...]
The post COVID-19 treatment: NIH study aims to determine safety and efficacy of experimental monoclonal antibodies appeared first on Outbreak News Today.